Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
For authors
About
Topic collections
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
For authors
About
Topic collections
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 69, Issue 11
Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original article
Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy
Online download statistics by month:
Online download statistics by month: April 2016 to October 2024
Abstract
Full
Pdf
Apr 2016
212
17
16
May 2016
104
16
10
Jun 2016
51
3
5
Jul 2016
18
6
4
Aug 2016
35
5
8
Sep 2016
205
3
2
Oct 2016
459
10
94
Nov 2016
409
11
56
Dec 2016
119
7
48
Jan 2017
140
4
4
Feb 2017
80
12
7
Mar 2017
59
17
6
Apr 2017
48
8
5
May 2017
35
8
3
Jun 2017
47
6
5
Jul 2017
58
2
2
Aug 2017
73
4
4
Sep 2017
82
8
4
Oct 2017
87
2
1
Nov 2017
92
4
4
Dec 2017
46
3
2
Jan 2018
77
7
1
Feb 2018
46
5
1
Mar 2018
101
3
1
Apr 2018
47
1
2
May 2018
59
0
0
Jun 2018
75
3
2
Jul 2018
48
3
2
Aug 2018
56
4
3
Sep 2018
31
2
1
Oct 2018
47
0
0
Nov 2018
37
0
0
Dec 2018
42
3
2
Jan 2019
34
3
2
Feb 2019
18
0
0
Mar 2019
28
2
3
Apr 2019
37
3
2
May 2019
32
4
2
Jun 2019
21
1
0
Jul 2019
23
1
0
Aug 2019
25
0
0
Sep 2019
38
0
0
Oct 2019
23
1
1
Nov 2019
21
0
2
Dec 2019
14
2
1
Jan 2020
20
3
2
Feb 2020
31
1
0
Mar 2020
32
2
1
Apr 2020
34
2
2
May 2020
44
1
1
Jun 2020
44
0
0
Jul 2020
28
0
1
Aug 2020
18
2
0
Sep 2020
22
0
0
Oct 2020
27
0
0
Nov 2020
31
3
3
Dec 2020
28
1
1
Jan 2021
24
1
1
Feb 2021
18
2
2
Mar 2021
35
1
1
Apr 2021
19
1
1
May 2021
11
1
1
Aug 2021
1
1
2
Sep 2021
1
1
1
Oct 2021
22
0
0
Nov 2021
30
2
0
Dec 2021
29
1
0
Jan 2022
30
2
0
Feb 2022
16
2
1
Mar 2022
31
1
0
Apr 2022
19
1
0
May 2022
59
0
0
Jun 2022
42
0
0
Jul 2022
26
4
3
Aug 2022
48
1
1
Sep 2022
56
1
0
Oct 2022
115
4
0
Nov 2022
30
1
1
Dec 2022
16
0
0
Jan 2023
25
2
2
Feb 2023
54
2
2
Mar 2023
10
2
0
Apr 2023
4
0
0
May 2023
41
1
0
Jun 2023
6
0
0
Jul 2023
3
1
0
Aug 2023
9
1
1
Sep 2023
3
1
0
Oct 2023
26
2
1
Nov 2023
133
0
0
Dec 2023
23
1
0
Jan 2024
14
0
0
Feb 2024
12
0
0
Mar 2024
41
1
1
Apr 2024
33
0
0
May 2024
34
0
0
Jun 2024
45
1
2
Jul 2024
21
0
0
Aug 2024
29
2
1
Sep 2024
26
4
0
Oct 2024
27
1
1
Total
5095
269
355
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?